January 17, 2017 — The size of the Taxotere MDL nearly tripled over the last four weeks, after 400 new cases were filed by cancer survivors who did not re-grow their hair after chemotherapy.
There are currently 705 lawsuits pending in the Taxotere Multi-District Litigation (MDL No. 2740) as of today. There were only 267 cases in the MDL on December 15, 2016, when federal judges issued their last update.
That means the total number of lawsuits nearly tripled with the filing of another 438 cases in the last month. The size of the MDL has skyrocketed since it was created in October 2016 with only 33 cases.
All of the lawsuits involve cancer survivors with permanent baldness — mostly breast cancer. About one-third of breast cancers are slow-growing and do not need aggressive treatment. Many women say they would have used other chemotherapy drugs that do not cause baldness if they had known about the risk.
Lawyers say Sanofi-Aventis knew about the side effect more than a decade ago, but did not update drug-labels in the U.S. until December 2015. Permanent alopecia was added to drug-labels in Canada in 2005, and in Europe in 2012.
The old label reassured women that “hair generally grows back” after completing chemotherapy. The new label warns, “In most cases, normal hair growth should return. In some cases (frequency not known) permanent hair loss has been observed.”
Need a Taxotere Lawyer in Texas?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Taxotere lawyers for a free lawsuit review.